← Back to Search

Conversation Therapy for Aphasia

N/A

Recruiting

Led By Elizabeth Hoover, PhD

Research Sponsored by Boston University Charles River Campus

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Clinical diagnosis of aphasia

Participants with severe aphasia (Cycle 2)

Must not have

No history of neurological disease (other than stroke)

No current serious medical illness (e.g., cancer)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and up to 12 weeks after baseline

Awards & highlights

No Placebo-Only Group

Summary

This trial will test the efficacy of group conversation treatment for people with aphasia, looking at factors such as group size and composition, and severity of aphasia.

Who is the study for?

This trial is for English-speaking adults with aphasia, a language disorder typically caused by stroke. They must be at least 6 months post-stroke and have enough understanding to join in conversations. The study includes all severity levels of aphasia but excludes those with other neurological diseases, developmental disabilities, or serious illnesses like cancer.

What is being tested?

The study tests group conversation treatment's effectiveness on communication skills in people with aphasia. It examines how different group sizes (2 vs. 6-8 people) and compositions (similar vs. different types of aphasia), as well as the severity of aphasia, impact the treatment outcome.

What are the potential side effects?

Since this is a non-medical intervention focusing on speech therapy through conversation practice, there are no direct medical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with difficulty in speaking or understanding language.

Select...

I have severe difficulty speaking or understanding speech.

Select...

I am a native English speaker.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have not had any neurological diseases, except for a stroke.

Select...

I do not have any serious illnesses right now.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and up to 12 weeks after baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and up to 12 weeks after baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and up to 12 weeks after baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Scores on Aphasia Communication Outcome Measure from Pre- to Post- Treatment

Change in Scores on Aphasia Communication Outcome Measure from Pre-Treatment to One month Post-Treatment

Secondary study objectives

Aphasia Tests

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Experimental: Group compositionExperimental Treatment1 Intervention

Outcomes will be measured for individuals who participate in homogeneous compared to heterogeneous groups (6-8 people with aphasia), based on aphasia severity (severe vs. mild-moderate aphasia).

Group II: Experimental: Group Size x Aphasia SeverityExperimental Treatment1 Intervention

Outcomes will be measured for individuals who participate in large group (6-8 group members) compared to dyads (2 group members), and whether this relationship differs as a function of aphasia severity (severe vs. mild-moderate aphasia).

Group III: Treatment efficacy: Delayed Control GroupActive Control1 Intervention

Treatment cycle 1 only.

0 / 5Eligibility criteria met